HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 23, No 09, September 2019 – Healthy Ageing — How Science is chipping in       » Officials in China make progress in development of new drugs       » The Science of Healthy Ageing       » Thailand Medtech landscape - Customer to Innovator       » China-Thailand Joint Research Institute on Medicine Launched in Bangkok      
INSIDE INDUSTRY
Australian medical life sciences company expands nutraceutical business to the USA
Medlab Clinical Ltd (MDC) signs a Heads of Agreement with the American Nutritional Corp Inc. (ANC), entering the US market using MDC’s existing nutraceutical products.

ANC is a US entity with audited and approved manufacturing capabilities for several extremely large institutional US brands.

The Australian based medical life science company, MDC develops therapeutic pathways for diagnosed chronic diseases as well as pain management, depression, and obesity. Several of MDC’s current, unique nutraceuticals are well positioned for ANC clients. This deal should see current MDC products enter both medical and consumer markets with larger, existing companies already strong in branding and distribution. Whilst Medlab will be featured on the label, the overall intent is to rebrand to suit the client’s general branding strategy.

Commercial terms and specific distribution partners are to be finalised through execution of a definitive commercial agreement. The first US launch of MDC products is predicted to occur within December 2019.

Medlab CEO, Dr Sean Hall said “having access to clients of this calibre and being able to tap into their supply chains is very exciting and a great opportunity to truly enter into the US nutraceutical market. It is our patents, research, and strong clinical capabilities that makes us attractive.”

In addition to the USA, MDC intends to venture into other potential international territories as a number of these institutional companies’ market internationally or are planning for expansion.

The agreement is also an opportunity to expand the relationship with ANC and capitalize on their manufacturing capabilities, providing ongoing economies of scale for the local market.

 

Click here for the complete issue.

NEWS CRUNCH  
news New computational fluid dynamics solution for modeling aerosol mixtures in biomedical and environmental research
news Medial Fair Thailand opened on 11th September 2019 with a focus on future-proofing Thailand's healthcare industry to meet the challenges and opportunities of the next decade
news Biofuel Producers and Users to Convene in Singapore for Global Biofuels Summit
news Philip Morris International opens artificial intelligence competition to develop improved strategies for medical diagnosis
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  
SPOTLIGHT  
LIFE OF A SCIENTIST  

APBN Editorial Calendar 2019
January:
Taiwan Medical tourism
February:
Marijuana as medicine — Legal marijuana will open up scientific research
March:
Driven by curiosity
April:
Career developments for researchers
May:
What's cracking — Antibodies in ostrich eggs
June:
Clinical trials — What's in a name?
July:
Traditional Chinese medicine in modern healthcare — Integrating both worlds
August:
Digitalization vs Digitization — Exploring Emerging Trends in Healthcare
September:
Healthy Ageing — How Science is chipping in
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2019 World Scientific Publishing Co Pte Ltd  •  Privacy Policy